期刊文献+

阿维A酸对系统性硬皮病患者成纤维细胞增殖及分泌TGF-β_1的影响 被引量:5

Effect of acitretin on the proliferation and TGF-β_1 secretion of fibroblasts in systemic sclerosis
下载PDF
导出
摘要 目的:确定阿维A酸对系统性硬皮病患者皮肤成纤维细胞增殖及分泌转化生长因子β1(TGF-β1)的影响。方法:原代培养系统性硬皮病(SSc)患者皮肤成纤维细胞(FB),使用不同浓度的阿维A酸作用48h,四甲基偶氮唑盐(MTT)方法及ELISA法测定阿维A酸对成纤维细胞增殖及分泌TGF-β1的影响。结果:阿维A酸可明显抑制患者皮肤成纤维细胞的增殖,显著减少成纤维细胞TGF-β1的分泌,并具有浓度依赖性。与空白对照组相比,差异有显著性(P<0.05)。结论:阿维A酸对SSc皮肤成纤维细胞的增殖及TGF-β1的分泌均有显著抑制作用,为其治疗硬皮病提供了理论基础。 Objective: To determine the effects of acitretin on the proliferation and transfer growth factor- β1 (TGF- β1 ) secretion of fibroblasts in systemic sclerosis (SSc). Methods: SSc dermal fibroblasts were primarily cultured, and were treated with different concentrations of acitretin for 48 h. The cell proliferation was determined by MTT assay, and the level of TGF - β1 measured with ELISA. Results: Acitretin not only inhibited the proliferation of the cultured dermal fibroblasts of SSc, but also reduced the secretion of TGF -β1 in a dose - dependent manner. There was significant difference compared with blank control (P 〈 0.05). Conclusion: Acitretin significantly inhibits the proliferation and TGF -β1 production in cultured SSc fibroblasts, which provides the base for the treatment of SSc.
出处 《中国麻风皮肤病杂志》 2008年第2期108-109,共2页 China Journal of Leprosy and Skin Diseases
关键词 系统性硬皮病 阿维A酸 成纤维细胞 TGF-Β1 systemic sclerosis acitretin cell proliferation TGF-β1
  • 相关文献

参考文献4

  • 1Brennan P, Silman A, Black C, et al. Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol 1992;31(7) :457 - 460.
  • 2Ikeda T, Uede K, Furukawa F, et al. The vitamin A derivate etretinate improve skin sclerosis in patients with systemic sclerosis. J Dermatol Science 2004;34:62 - 66.
  • 3Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. I: Local injection of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999; 12(4) :456- 462.
  • 4Mcgaha T, Saito S, Phelps RG, et al. Lack of skin fibrosis in fight skin(TSK) mice with targeted mutation in the interleukin- 4R alpha and transforming growth factorbeta genes. J Invest Dermatol 2001;116(1):136- 143.

同被引文献43

  • 1徐琳,李志梁,赵连友,刘映峰,李公信,丁明学,赵一俏,傅强,赵霞.辛伐他汀对鼠心脏成纤维细胞DNA合成的影响[J].南方医科大学学报,2006,26(2):205-207. 被引量:10
  • 2张彩香,李红,刘章锁.辛伐他汀抑制肾间质纤维化的实验研究[J].山西医药杂志,2006,35(4):286-288. 被引量:3
  • 3钱革,王千秋,张国成.他汀类药物在皮肤科的应用展望[J].国际皮肤性病学杂志,2006,32(3):139-141. 被引量:4
  • 4崔盘根,李晶冰,张彩萍,王淼淼,张传福,蒋明军,林麟.阿维A联合血管扩张剂治疗6例系统性硬皮病疗效观察[J].临床皮肤科杂志,2007,36(2):113-114. 被引量:6
  • 5WATTS K L, SAMPSON E M, SCHULTZ G S,et al. Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts[J]. Am J Respir Cell Mol Biol,2005 ,32(4) :290 -300.
  • 6OHTSUKA T, KOIBUCHI N, SAKAI H, et al. Quantitative analysis of α1(Ⅰ)and α1(Ⅲ) procollagen mRNA expression in systemic sclerosis skin tissue-an in situ hybridization study [ J ]. Arch Dermatol Res, 1999, 291(11) :575 -582.
  • 7Furst DE,Clement PJ.Hypothesis for the pathogenesis of systemic sclerosis.J Rheumatol 1997;(suppl 48):53-57.
  • 8Clements PJ,Furst DE,Wong WK,et al.High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis:analysis of a two-year,double-blind,randomized,controlled clinical trial[J].Arthritis Rheum,1999,42(6):1194-1203.
  • 9Derk CT,Huaman G,Jimenez SA.A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset[J].Br J Dermatol,2008,158(5):1063-1068.
  • 10Giordano N,Papakostas P,Lucani B,et al.Serum relaxin in systemic sclerosis[J].J Rheumatol,2005,32(11):2164-2166.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部